PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.39 -0.01 (-1.63%)
As of: Nov 12, 2026 · 10:14 AM EST

PharmaCyte Biotech (PMCB) Receivables (2009 - 2026)

Updated

PharmaCyte Biotech (PMCB) recorded Receivables of $3.36 million in fiscal Q3 2025 (quarter ended Jan 31, 2025).

Analysis

PharmaCyte Biotech (PMCB) Receivables (2009 - 2026) Analysis & Trends

At the end of FY2024 (ended Apr 30, 2024), PharmaCyte Biotech reported Receivables of $2.76 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 25.23 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 18.99 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 13.51 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 12.74 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 16.16 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.35 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 5.01 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.19 Bn
10 PharmaCyte Biotech 4.29 Mn -68.55 Mn - 429,150.00
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 429,150.00
Apr 30, 2026 240,766.00
Jan 31, 2025 3.36 Mn
Apr 30, 2024 2.76 Mn
Apr 30, 2012 1.03 Mn
Jan 31, 2012 19,579.00
Oct 31, 2011 8,962.00
Jul 31, 2011 8,607.00
Apr 30, 2011 2,316.00
Jan 31, 2011 30,342.00
Oct 31, 2010 13,025.00
Jul 31, 2010 4,348.00
Apr 30, 2010 10,435.00
Jan 31, 2010 31,058.00
Oct 31, 2009 62,306.00
Jul 31, 2009 28,838.00
Apr 30, 2009 156,312.00
Jan 31, 2009 140,213.00
API Access

PharmaCyte Biotech Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=PMCB&period=max&api_key=YOUR_API_KEY